Filed before 2025Filed 16 May 2018
Fog Pharmaceuticals, Inc. has sold $65.5M so far
Fog Pharmaceuticals, Inc., a pharmaceuticals company based in Cambridge, MA, has sold $65.5M so far in its equity round, according to a filing dated 16 May 2018.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 16 May 2018
- First filed
- 14 February 2018
- Round
- Equity round (amended filing)
- Amount sold
- $65.5M
- Offering size
- $66M
- Investors so far
- 24
- Based in
- Cambridge, MA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 94% of the 1,729 tracked raises with an amount filed in 2018, and than 93% of the 42 in pharmaceuticals.
Fog Pharmaceuticals, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 2 Dec 2022 | New filing | $178M | Another raise |
| 5 Jan 2021 | New filing | $23.3M | Another raise |
| 16 May 2018 | Amended filing | $65.5M | This raise |
| 14 Feb 2018 | New filing | $35M | This raise |
More with 6 Dimensions Capital on the board
- Plexium, Inc.$60.1M
- Vivace Therapeutics, Inc.$17.5M
- Eikon Therapeutics, Inc.$351M
- Seranova Bio, Inc.$10M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.